Celgene (CELG) Tops Q4 EPS by 2c, Offers FY17 Guidance

Celgene (NASDAQ: CELG) reported Q4 EPS of $1.61, $0.02 better than the analyst estimate of $1.59. Revenue for the quarter came in at $2.98 billion versus the consensus estimate of $3.02 billion.

GUIDANCE:

Celgene sees FY2017 EPS of $7.10-$7.25, versus the consensus of $7.13. Celgene sees FY2017 revenue of $13-13.4 billion, versus the consensus of $13.3 billion.

For earnings history and earnings-related data on Celgene (CELG) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Reading (RDI) Tops Q2 EPS by 4c